Investigation of Efficacy and Safety of EPOGAM

Inclusion Criteria: * atopic dermatitis since at least 2 months (criteria after Hanifin and Rajka, 1980) * men or women aged 2 - 45 years * women of childbearing age using contraception * informed consent of the patient or of the parents Exclusion Criteria: * psychiatric disorder * abuse of drugs or alcohol * chronic dermatosis * glaucoma, cataract or ocular herpes simplex * Immune deficiency * Immunological diseases * clinical relevant changes in laboratory parameters * congenital diseases * scabies, infections with dermathophytae, HIV-associated dermatosis * malignant diseases * metabolic diseases * parasites * patients enrolled in other studies * progredient, systemic diseases * pregnancy and lactation * severe internistic diseases * organ transplantation in the medical history * hypersensitivity against an ingredient of the study medication